Ocean Biomedical, Inc.

Ocean Biomedical, Inc. trades on Nasdaq under the ticker AEHA following its business combination with Aesther Healthcare Acquisition Corp., a blank-check company that completed its initial public offering in 2021. The SPAC was sponsored by Aesther Healthcare Management LLC and was focused on the healthcare and life sciences sector. Ocean Biomedical is a biopharmaceutical company developing novel therapies across oncology, pulmonary fibrosis, and infectious disease, drawing on research originating from Brown University. The company filed an 8-K with the SEC on July 23, 2024, disclosing a current reportable event. Sign up at SpacDesk for full filing history, sponsor profiles, and deal analytics on AEHA and hundreds of other SPAC transactions.